Try our Advanced Search for more refined results

March 29, 2019

Genentech, Inc. et al v. Immunex Rhode Island Corp. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 22, 2019

    Amgen, Allergan Launch 2 Biosimilars With Court's Blessing

    Amgen and Allergan have started selling their biosimilar versions of Genentech's blockbuster cancer treatments Avastin and Herceptin in the U.S., announcing the launch immediately after a Delaware federal judge refused to block the sales.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login